Cyrusone Inc (CONE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2011 | 12-2010 | |
| Assets | ||
| Cash & Cash Equivalents | 600 | 0 |
| Other assets | 954,100 | 0 |
| Total Assets | $954,700 | $0 |
| Liabilities | ||
| Long Term Debt | 48,200 | 0 |
| Payables And Accrued Expenses | 502,400 | 0 |
| Other liabilities | 572,800 | 0 |
| Total Liabilities | $643,200 | $0 |
| Shareholders' Equity | ||
| Other shareholders' equity | 311,500 | 0 |
| TOTAL | $311,500 | $0 |
| Total Liabilities And Equity | $954,700 | $0 |